![Paul R. Fonteyne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul R. Fonteyne
Directeur/Membre du Conseil chez
AMYLYX PHARMACEUTICALS, INC.
Fortune : 70 888 $ au 30/06/2026
Profil
Mr. Paul R.
Fonteyne is an Independent Director at Apnimed, Inc., an Independent Director at Amylyx Pharmaceuticals, Inc., a Chairman at DalCor Pharmaceuticals Canada, Inc. and an Independent Non-Executive Director at Ypsomed Holding AG.
He is on the Board of Directors at Apnimed, Inc., Amylyx Pharmaceuticals, Inc., Ypsomed AG, Ypsomed Holding AG, Allyx Therapeutics, Inc., DalCor Pharma UK Ltd. and Revelar Biotherapeutics, Inc. Mr. Fonteyne was previously employed as an Independent Director by Gelesis Holdings, Inc., an Independent Director by Covetrus, Inc., a Chief Executive Officer by Thyron Pharmaceuticals, Inc., an Independent Director by Apellis Pharmaceuticals, Inc., an Independent Director by AMAG Pharmaceuticals, Inc., a President by Boehringer Ingelheim Vetmedica, Inc., an Independent Director by resTORbio, Inc., a President & Chief Executive Officer by Boehringer Ingelheim Pharmaceuticals, Inc., a Chairman, President, Chief Executive Officer & MD by Boehringer Ingelheim Corp., a Senior VP-Prescription Medicines Marketing by Boehringer Ingelheim GmbH, a Vice President-Sales by Merck & Co., Inc., a Chairman-New England by American Cancer Society, Inc., and a Chairman by National Pharmaceutical Council.
He also served on the board at Gelesis, Inc. and Pharmaceutical Research & Manufacturers of America.
He received his graduate degree from Université Libre de Bruxelles and an MBA from Carnegie Mellon University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/06/2026 | 3 947 ( 0 % ) | 70 888 $ | 30/06/2026 | |
APNIMED, INC. -.--% | 30/07/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Paul R. Fonteyne
| Sociétés | Poste | Début |
|---|---|---|
| YPSOMED HOLDING AG | Directeur/Membre du Conseil | 01/01/2018 |
| AMYLYX PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 29/03/2021 |
| APNIMED, INC. | Directeur/Membre du Conseil | 02/10/2023 |
Ypsomed AG
 Ypsomed AG Medical SpecialtiesHealth Technology Manufactures injection and infusion systems for self-medication and renowned diabetes | Directeur/Membre du Conseil | 01/01/2018 |
DalCor Pharma UK Ltd.
 DalCor Pharma UK Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Directeur/Membre du Conseil | 27/02/2019 |
Revelar Biotherapeutics, Inc.
 Revelar Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | - |
Allyx Therapeutics, Inc.
 Allyx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops therapies to protect synapses from destruction in Alzheimer's and related neurodegenerative diseases | Fondateur | - |
DalCor Pharmaceuticals Canada, Inc.
 DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Develops precision treatments for cardiovascular disease | Président | 27/02/2019 |
Anciens postes connus de Paul R. Fonteyne
| Sociétés | Poste | Fin |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 14/05/2026 |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Paul R. Fonteyne
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
25
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Health Technology |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops novel category of therapies for GI-related chronic diseases | Health Technology |
Apellis Pharmaceuticals, Inc.
 Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
Ypsomed Holding AG
 Ypsomed Holding AG Medical SpecialtiesHealth Technology Manufactures injections and diagnostic devices | Health Technology |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Commercial Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Health Technology |
Université Libre de Bruxelles
 Université Libre de Bruxelles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Animal Health USA, Inc.
 Boehringer Ingelheim Animal Health USA, Inc. BiotechnologyHealth Technology Manufactures biological vaccines for animals | Health Technology |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services Operates as a not for profit organization which specializes in research development, information dissemination, education and communication of information to patients | Commercial Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ypsomed AG
Ypsomed AG Medical SpecialtiesHealth Technology Manufactures injection and infusion systems for self-medication and renowned diabetes | Health Technology |
Amylyx Pharmaceuticals, Inc.
 Amylyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products to cure neurodegenerative diseases | Health Technology |
DalCor Pharmaceuticals Canada, Inc.
DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Develops precision treatments for cardiovascular disease | Health Technology |
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Covetrus, Inc.
 Covetrus, Inc. Packaged SoftwareTechnology Services Provides veterinary-practice software services | Technology Services |
Apnimed, Inc.
 Apnimed, Inc. BiotechnologyHealth Technology Engages in developing and commercializing of proprietary therapeutics for sleep apnea & breathing diseases | Health Technology |
DalCor Pharma UK Ltd.
DalCor Pharma UK Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Allyx Therapeutics, Inc.
Allyx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops therapies to protect synapses from destruction in Alzheimer's and related neurodegenerative diseases | Commercial Services |
Revelar Biotherapeutics, Inc.
Revelar Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Gelesis Holdings, Inc.
 Gelesis Holdings, Inc. Medical SpecialtiesHealth Technology Develops superabsorbent hydrogel therapeutics for chronic gastrointestinal, weight management and diabetes | Health Technology |
Thyron Pharmaceuticals, Inc.
 Thyron Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Develops synthetic biotechnology platform for bio-manufacturing | Technology Services |
